A new study is raising more concern about the effectiveness of two popular cholesterol lowering drugs-- Zetia and Vytorin.
Researchers report that Zetia failed to reduce artery buildup and users of the medication suffered more heart attacks than those on rival drug, Niaspan.
A trial of Vytorin also showed little or no benefit against heart disease.
SOURCE - Johns Hopkins/New England Journal of Medicine
Email
Facebook
Google
Twitter
Favorites
More
Advertisement